Mechanical circulatory support (MCS) evolved from an engineering dream to clinical reality
during the 1980s when increasing numbers of patients were dying on heart transplant wait …

Cardiogenic shock is the clinical expression of circulatory failure, as a consequence of left,
right or biventricular dysfunction. Cardiogenic shock is also defined as a state of critical end …

Objective To highlight recent developments in the utilization of mechanical circulatory
support (MCS) devices as bridge-to-transplant strategies and to discuss trends in MCS use …

The use of reperfusion therapy has substantially reduced 30-day mortality in acute ST-
segment elevation myocardial infarction(STEMI) patients. w1ew3 Currently, the optimal …

Background Mechanical circulatory support (MCS) devices, such as ventricular assist
devices (VADs) and total artificial hearts (TAHs), have become a vital therapeutic option in …

We introduce an implantable intracardiac soft robotic right ventricular ejection device
(RVED) for dynamic approximation of the right ventricular (RV) free wall and the …

Hemocompatibility of blood pumps is a crucial parameter that has to be ensured prior to in
vivo testing. In contrast to rotary blood pumps, a standard for testing a pulsatile total artificial …

Background: Heart failure is one of the most expensive chronic diseases, as it leads to
considerable expenses due to increasing hospitalisation rates. In addition to the implications …

Cardiogenic shock (CS) is a hemodynamically complex and highly morbid syndrome
characterized by circulatory collapse and inadequate end-organ perfusion due to impaired …

Aims Despite improved outcomes and lower right ventricular failure (RVF) rates with
continuous-flow left ventricular assist devices (LVADs), RVF still occurs in 20-40% of LVAD …